Control of cyclin-dependent kinase 5 (Cdk5) activity by glutamatergic regulation of p35 stability

被引:80
作者
Wei, FY
Tomizawa, K
Ohshima, T
Asada, A
Saito, T
Nguyen, C
Bibb, JA
Ishiguro, K
Kulkarni, AB
Pant, HC
Mikoshiba, K
Matsui, H
Hisanaga, S [1 ]
机构
[1] Tokyo Metropolitan Univ, Grad Sch Sci, Dept Sci Biol, Hachioji, Tokyo 1920397, Japan
[2] Okayama Univ, Grad Sch Med & Dent, Dept Physiol, Okayama, Japan
[3] Brain Sci Inst, Dev Neurobiol Lab, Wako, Saitama, Japan
[4] Univ Texas, SW Med Ctr, Dept Psychiat, Dallas, TX USA
[5] Mitsubishi Kagaku Inst Life Sci, Tokyo, Japan
[6] NINDS, Funct Genom Unit, Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD USA
[7] NINDS, Lab Neurochem, NIH, Bethesda, MD USA
关键词
calmodulin; cyclin-dependent kinase 5; proteasome; glutamate; N-methyl-D-aspartate; long-term potentiation;
D O I
10.1111/j.1471-4159.2005.03058.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Although the roles of cyclin-dependent kinase 5 (Cdk5) in neurodevelopment and neurodegeneration have been studied extensively, regulation of Cdk5 activity has remained largely unexplored. We report here that glutamate, acting via NMDA or kainate receptors, can induce a transient Ca2+/calmodulin-dependent activation of Cdk5 that results in enhanced autophosphorylation and proteasome-dependent degradation of a Cdk5 activator p35, and thus ultimately down-regulation of Cdk5 activity. The relevance of this regulation to synaptic plasticity was examined in hippocampal slices using theta burst stimulation. p35(-/-) mice exhibited a lower threshold for induction of long-term potentiation. Thus excitatory glutamatergic neurotransmission regulates Cdk5 activity through p35 degradation, and this pathway may contribute to plasticity.
引用
收藏
页码:502 / 512
页数:11
相关论文
共 51 条
[1]
Cyclin-dependent kinase 5 (cdk5) activation requires interaction with three domains of p35 [J].
Amin, ND ;
Albers, W ;
Pant, HC .
JOURNAL OF NEUROSCIENCE RESEARCH, 2002, 67 (03) :354-362
[2]
Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons [J].
Bibb, JA ;
Snyder, GL ;
Nishi, A ;
Yan, Z ;
Meijer, L ;
Fienberg, AA ;
Tsai, LH ;
Kwon, YT ;
Girault, JA ;
Czernik, AJ ;
Huganir, RL ;
Hemmings, HC ;
Nairn, AC ;
Greengard, P .
NATURE, 1999, 402 (6762) :669-671
[3]
BIBB JA, 2001, J BIOL CHEM, V276
[4]
Kainate receptors are involved in synaptic plasticity [J].
Bortolotto, ZA ;
Clarke, VRJ ;
Delany, CM ;
Parry, MC ;
Smolders, I ;
Vignes, M ;
Ho, KH ;
Miu, P ;
Brinton, BT ;
Fantaske, R ;
Ogden, A ;
Gates, M ;
Ornstein, PL ;
Lodge, D ;
Bleakman, D ;
Collingridge, GL .
NATURE, 1999, 402 (6759) :297-301
[5]
Bu BT, 2002, J NEUROSCI, V22, P6515
[6]
Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia [J].
Caporaso, GL ;
Bibb, JA ;
Snyder, GL ;
Valle, C ;
Rakhilin, S ;
Fienberg, AA ;
Hemmings, HC ;
Nairn, AC ;
Greengard, P .
NEUROPHARMACOLOGY, 2000, 39 (09) :1637-1644
[7]
Mice lacking p35, a neuronal specific activator of Cdk5, display cortical lamination defects, seizures, and adult lethality [J].
Chae, T ;
Kwon, YT ;
Bronson, R ;
Dikkes, P ;
Li, E ;
Tsai, LH .
NEURON, 1997, 18 (01) :29-42
[8]
Molecular heterogeneity of central synapses: afferent and target regulation [J].
Craig, AM ;
Boudin, H .
NATURE NEUROSCIENCE, 2001, 4 (06) :569-578
[9]
Dhavan R, 2002, J NEUROSCI, V22, P7879
[10]
A decade of CDK5 [J].
Dhavan, R ;
Tsai, LH .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2001, 2 (10) :749-759